Weekly civic intelligence report · v2.2
Trump signed an executive order expediting the reclassification of marijuana as a less dangerous drug, following lobbying from the cannabis industry. The order could expand access to marijuana and lower taxes on cannabis businesses. This represents a shift in federal drug policy.
A-score: Rule of law (2) for administrative reclassification process, separation (1) for executive action on regulatory matter, civil rights (3) for criminal justice implications and personal liberty expansion, capture (2) for explicit industry lobbying influence. Severity: durability 1.1 (requires DEA action, somewhat durable), reversibility 0.9 (administratively reversible), precedent 1.0 (follows existing process). Mechanism modifier 1.15 for policy_change with regulatory pathway. Scope 1.2 for federal/broad. Base: (0×0.22 + 2×0.18 + 1×0.16 + 3×0.14 + 2×0.14 + 0×0.10 + 0×0.06) × 1.0 × 1.15 × 1.2 = 16.42. B-score: Layer1 (55%): outrage 3 (conservative opposition noted), meme 2 (weed policy shift), novelty 3 (Trump policy reversal), media 4 (highly covered) = 12/20 × 55 = 33. Layer2 (45%): mismatch 2 (Trump vs conservative base), timing 1, narrative_pivot 3 (from law-and-order to liberalization), pattern 2 = 8/20 × 45 = 18. Intentionality 7/15 (explicit lobbying, narrative shift) = 0.55 weight. Final: 33 + (18 × 0.55) = 25.08. D-score: 16.42 - 25.08 = -8.66. B>=25 AND D<=-8.66 qualifies as List B.
Monitor actual DEA reclassification timeline and implementation. Track whether this represents substantive policy change or symbolic gesture. Assess if this distracts from other regulatory/enforcement actions. Note industry capture dynamics and whether reclassification materializes or remains aspirational.